A focus on structural brain imaging in the Alzheimer's Disease Neuroimaging Initiative

Biological Psychiatry

Volumn 75, Issue 7, 2014, Pages 527-533

  Braskie, Meredith N ^a   Thompson, Paul M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; atrophy; biomarkers; brain volume; cognition; cognitive decline; conversion; dementia; hippocampus; magnetic resonance imaging; mild cognitive impairment; MRI; predict; progression; temporal lobe

Indexed keywords

ALZHEIMER DISEASE; COGNITION; COGNITIVE DEFECT; DIAGNOSIS RELATED GROUP; DISEASE COURSE; DISEASE MARKER; ENVIRONMENTAL FACTOR; GENETIC RISK; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ALZHEIMER'S DISEASE; ATROPHY; BIOMARKERS; BRAIN VOLUME; COGNITION; COGNITIVE DECLINE; CONVERSION; DEMENTIA; HIPPOCAMPUS; MAGNETIC RESONANCE IMAGING; MILD COGNITIVE IMPAIRMENT; MRI; PREDICT; PROGRESSION; TEMPORAL LOBE;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; COGNITION; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84896330212     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.11.020     Document Type: Review

References (100)

1. K.A. Ellis, A.I. Bush, D. Darby, D. De Fazio, J. Foster, and P. Hudson et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease Int Psychogeriatr 21 2009 672 687
2. K.L. Lunetta, P.M. Erlich, K.T. Cuenco, L.A. Cupples, R.C. Green, L.A. Farrer, and C. Decarli Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study Alzheimer Dis Assoc Disord 21 2007 85 91
3. B. Winblad, G.B. Frisoni, L. Frolich, P. Johannsen, G. Johansson, and P. Kehoe et al. Editorial: EADC (European Alzheimer Disease Consortium) recommendations for future Alzheimer disease research in Europe J Nutr Health Aging 12 2008 683 684
4. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, and R.C. Green et al. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception Alzheimers Dement 9 2013 e111 e194
5. M.N. Braskie, J.M. Ringman, and P.M. Thompson Neuroimaging measures as endophenotypes in Alzheimer's disease Int J Alzheimers Dis 2011 2011 490140
6. L. Shen, P.M. Thompson, S.G. Potkin, L. Bertram, L.A. Farrer, and T.M. Foroud et al. Genetic analysis of quantitative phenotypes in AD and MCI: Imaging, cognition and biomarkers [published online ahead of print Oct 5] Brain Imaging Behav 2013
7. M.N. Braskie, A.W. Toga, and P.M. Thompson Recent advances in imaging Alzheimer's disease J Alzheimers Dis 33 suppl 1 2013 S313 S327
8. M.W. Vernooij, and M. Smits Structural neuroimaging in aging and Alzheimer's disease Neuroimaging Clin N Am 22 2012 33 55
9. M. Schuur, J.C. van Swieten, S. Schol-Gelok, M.A. Ikram, M.W. Vernooij, and F. Liu et al. Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population J Neurol Neurosurg Psychiatry 82 2011 41 44
10. M.N. Braskie, and P.M. Thompson Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings Trends Cogn Sci 17 2013 510 516
11. A.M. Fjell, and K.B. Walhovd New tools for the study of Alzheimer's disease: What are biomarkers and morphometric markers teaching us? Neuroscientist 17 2011 592 605
12. C.R. Jack Jr, D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, and M.W. Weiner et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
13. C.R. Jack Jr, D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, and P.S. Aisen et al. Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216
14. H. Braak, and E. Braak Frequency of stages of Alzheimer-related lesions in different age categories Neurobiol Aging 18 1997 351 357
15. D.S. Knopman, C.R. Jack Jr, H.J. Wiste, S.D. Weigand, P. Vemuri, and V.J. Lowe et al. Brain injury biomarkers are not dependent on beta-amyloid in normal elderly Ann Neurol 73 2013 472 480
16. R.Y. Lo, A.E. Hubbard, L.M. Shaw, J.Q. Trojanowski, R.C. Petersen, and P.S. Aisen et al. Longitudinal change of biomarkers in cognitive decline Arch Neurol 68 2011 1257 1266
17. S.M. Landau, M.A. Mintun, A.D. Joshi, R.A. Koeppe, R.C. Petersen, and P.S. Aisen et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline Ann Neurol 72 2012 578 586
18. C.R. Jack Jr, P. Vemuri, H.J. Wiste, S.D. Weigand, P.S. Aisen, and J.Q. Trojanowski et al. Evidence for ordering of Alzheimer disease biomarkers Arch Neurol 68 2011 1526 1535
19. A. Caroli, and G.B. Frisoni The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort Neurobiol Aging 31 2010 1263 1274
20. M. Ewers, P. Insel, W.J. Jagust, L. Shaw, J.Q. Trojanowski, and P. Aisen et al. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects Cerebral Cortex 22 2012 1993 2004
21. S.D. Han, J. Gruhl, L. Beckett, H.H. Dodge, N.H. Stricker, and S. Farias et al. Beta amyloid, tau, neuroimaging, and cognition: Sequence modeling of biomarkers for Alzheimer's disease Brain Imaging Behav 6 2012 610 620
22. M.R. Sabuncu, R.S. Desikan, J. Sepulcre, B.T. Yeo, H. Liu, and N.J. Schmansky et al. The dynamics of cortical and hippocampal atrophy in Alzheimer disease Arch Neurol 68 2011 1040 1048
23. G.C. Chiang, P.S. Insel, D. Tosun, N. Schuff, D. Truran-Sacrey, and S.T. Raptentsetsang et al. Impact of ApoE4-CSF Abeta interaction on hippocampal volume loss over 1 year in MCI Alzheimer Dement 7 2011 514 520
24. O. Carmichael, D.G. McLaren, D. Tommet, D. Mungas, and R.N. Jones Coevolution of brain structures in amnestic mild cognitive impairment Neuroimage 66C 2012 449 456
25. P. Buchhave, L. Minthon, H. Zetterberg, A.K. Wallin, K. Blennow, and O. Hansson Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia Arch Gen Psychiatry 69 2012 98 106
26. E.C. Mormino, J.T. Kluth, C.M. Madison, G.D. Rabinovici, S.L. Baker, and B.L. Miller et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects Brain 132 2009 1310 1323
27. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
28. H.D. Protas, K. Chen, J.B. Langbaum, A.S. Fleisher, G.E. Alexander, and W. Lee et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease JAMA Neurol 70 2013 320 325
29. E.M. Reiman, K. Chen, G.E. Alexander, R.J. Caselli, D. Bandy, and D. Osborne et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc Natl Acad Sci U S A 101 2004 284 289
30. A.S. Fleisher, K. Chen, X. Liu, N. Ayutyanont, A. Roontiva, and P. Thiyyagura et al. Apolipoprotein E epsilon4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease Neurobiol Aging 34 2013 1 12
31. W. Jagust Apolipoprotein E, neurodegeneration, and Alzheimer disease JAMA Neurol 70 2013 299 300
32. R.J. Bateman, C. Xiong, T.L. Benzinger, A.M. Fagan, A. Goate, and N.C. Fox et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease N Engl J Med 367 2012 795 804
33. N. Schuff, D. Tosun, P.S. Insel, G.C. Chiang, D. Truran, and P.S. Aisen et al. Nonlinear time course of brain volume loss in cognitively normal and impaired elders Neurobiol Aging 33 2012 845 855
34. C.R. Jack Jr, V.J. Lowe, S.D. Weigand, H.J. Wiste, M.L. Senjem, and D.S. Knopman et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease Brain 132 2009 1355 1365
35. A. Mouiha, and S. Duchesne Toward a dynamic biomarker model in Alzheimer's disease J Alzheimer Dis 30 2012 91 100
36. W.K. Thompson, J. Hallmayer, and R. O'Hara Design considerations for characterizing psychiatric trajectories across the lifespan: application to effects of APOE-epsilon4 on cerebral cortical thickness in Alzheimer's disease Am J Psychiatry 168 2011 894 903
37. D. Holland, R.S. Desikan, A.M. Dale, and L.K. McEvoy Rates of decline in Alzheimer disease decrease with age PLoS One 7 2012 e42325
38. M.N. Samtani, M. Farnum, V. Lobanov, E. Yang, N. Raghavan, A. Dibernardo, and V. Narayan An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative J Clin Pharmacol 52 2012 629 644
39. X. Song, A. Mitnitski, N. Zhang, W. Chen, and K. Rockwood Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative J Neurol Neurosurg Psychiatry 84 2013 71 78
40. C.M. Stonnington, C. Chu, S. Kloppel, C.R. Jack Jr, J. Ashburner, and R.S. Frackowiak Predicting clinical scores from magnetic resonance scans in Alzheimer's disease Neuroimage 51 2010 1405 1413
41. B.C. Dickerson, and D.A. Wolk Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics J Neurol Neurosurg Psychiatry 82 2011 45 51
42. M.C. Evans, J. Barnes, C. Nielsen, L.G. Kim, S.L. Clegg, and M. Blair et al. Volume changes in Alzheimer's disease and mild cognitive impairment: Cognitive associations Eur Radiol 20 2010 674 682
43. K. Nho, S.L. Risacher, P.K. Crane, C. DeCarli, M.M. Glymour, and C. Habeck et al. Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease Brain Imaging Behav 6 2012 551 567
44. C.C. Rowe, K.A. Ellis, M. Rimajova, P. Bourgeat, K.E. Pike, and G. Jones et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Neurobiol Aging 31 2010 1275 1283
45. L.G. Apostolova, J.H. Morra, A.E. Green, K.S. Hwang, C. Avedissian, and E. Woo et al. Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects Neuroimage 51 2010 488 499
46. A.D. Leow, I. Yanovsky, N. Parikshak, X. Hua, S. Lee, and A.W. Toga et al. Alzheimer's disease neuroimaging initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition Neuroimage 45 2009 645 655
47. O. Carmichael, J. Xie, E. Fletcher, B. Singh, and C. DeCarli Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume Neurobiol Aging 33 1124 2012 e31 41
48. V.A. Guzman, O.T. Carmichael, C. Schwarz, G. Tosto, M.E. Zimmerman, and A.M. Brickman White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment Alzheimer Dement 9 5 suppl 2013 S124 S131
49. D. Tosun, N. Schuff, L.M. Shaw, J.Q. Trojanowski, and M.W. Weiner Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data J Alzheimer Dis 26 suppl 3 2011 77 90
50. L.G. Apostolova, K.S. Hwang, J.P. Andrawis, A.E. Green, S. Babakchanian, and J.H. Morra et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects Neurobiol Aging 31 2010 1284 1303
51. N.H. Stricker, H.H. Dodge, N.M. Dowling, S.D. Han, E.A. Erosheva, and W.J. Jagust CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade Brain Imaging Behav 6 2012 599 609
52. D. Varges, K. Jung, J. Gawinecka, U. Heinemann, M. Schmitz, and N. von Ahsen et al. Amyloid-beta 1-42 levels are modified by apolipoprotein E epsilon4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease J Alzheimer Dis 23 2011 717 726
53. J.A. Prince, H. Zetterberg, N. Andreasen, J. Marcusson, and K. Blennow APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42 Neurology 62 2004 2116 2118
54. C.A. Hostage, K. Roy Choudhury, P.M. Doraiswamy, and J.R. Petrella Dissecting the gene dose-effects of the APOE epsilon4 and epsilon2 alleles on hippocampal volumes in aging and Alzheimer's disease PLoS One 8 2013 e54483
55. A.C. Burggren, M.M. Zeineh, A.D. Ekstrom, M.N. Braskie, P.M. Thompson, and G.W. Small et al. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers Neuroimage 41 2008 1177 1183
56. Y. Liu, T. Paajanen, E. Westman, L.O. Wahlund, A. Simmons, and C. Tunnard et al. Effect of APOE epsilon4 allele on cortical thicknesses and volumes: The AddNeuroMed study J Alzheimer Dis 21 2010 947 966
57. S.G. Mueller, and M.W. Weiner Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields Hippocampus 19 2009 558 564
58. J.H. Morra, Z. Tu, L.G. Apostolova, A.E. Green, C. Avedissian, and S.K. Madsen et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls Neuroimage 45 2009 S3 S15
59. N. Schuff, N. Woerner, L. Boreta, T. Kornfield, L.M. Shaw, and J.Q. Trojanowski et al. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers Brain 132 2009 1067 1077
60. G. Ziegler, R. Dahnke, and C. Gaser Models of the aging brain structure and individual decline Front Neuroinform 6 2012 3
61. G.C. Chiang, P.S. Insel, D. Tosun, N. Schuff, D. Truran-Sacrey, and S. Raptentsetsang et al. Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes Radiology 259 2011 844 851
62. B.C. Dickerson, and D.A. Wolk MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults Neurology 78 2012 84 90
63. J. Nettiksimmons, D. Harvey, J. Brewer, O. Carmichael, C. DeCarli, and C.R. Jack Jr et al. Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline Neurobiol Aging 31 2010 1419 1428
64. E.A. Murphy, D. Holland, M. Donohue, L.K. McEvoy, D.J. Hagler Jr, and A.M. Dale et al. Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls Neuroimage 53 2010 1310 1317
65. C.D. Smith, A.H. Andersen, and B.T. Gold Structural brain alterations before mild cognitive impairment in ADNI: Validation of volume loss in a predefined antero-temporal region J Alzheimer Dis 31 Suppl 3 2012 S49 S58
66. M. Lehmann, E.L. Koedam, J. Barnes, J.W. Bartlett, F. Barkhof, and M.P. Wattjes et al. Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers Neurobiol Aging 34 2013 73 82
67. K.E. Macdonald, J.W. Bartlett, K.K. Leung, S. Ourselin, and J. Barnes The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD Alzheimer Dis Assoc Disord 27 2013 168 173
68. S.J. Greene, and R.J. Killiany Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease Neurobiol Aging 31 2010 1304 1311
69. S.L. Risacher, A.J. Saykin, J.D. West, L. Shen, H.A. Firpi, and B.C. McDonald Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort Curr Alzheimer Res 6 2009 347 361
70. N. Zhang, X. Song, Y. Zhang, W. Chen, R.C. D'Arcy, and S. Darvesh et al. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: A follow-up study J Alzheimer Dis 26 suppl 3 2011 359 367
71. C. Davatzikos, P. Bhatt, L.M. Shaw, K.N. Batmanghelich, and J.Q. Trojanowski Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification Neurobiol Aging 32 2322 2011 e19 27
72. N. Zhang, X. Song, and Y. Zhang Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment Dement Geriatr Cogn Disord 33 2012 318 326
73. E. Westman, C. Aguilar, J.S. Muehlboeck, and A. Simmons Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment Brain Topogr 26 2013 9 23
74. E. Westman, A. Simmons, J.S. Muehlboeck, P. Mecocci, B. Vellas, and M. Tsolaki et al. AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America Neuroimage 58 2011 818 828
75. G. Spulber, A. Simmons, J.S. Muehlboeck, P. Mecocci, B. Vellas, and M. Tsolaki et al. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment J Intern Med 273 2013 396 409
76. Y. Aksu, D.J. Miller, G. Kesidis, D.C. Bigler, and Q.X. Yang An MRI-derived definition of MCI-to-AD conversion for long-term, automatic prognosis of MCI patients PLoS One 6 2011 e25074
77. A. Chincarini, P. Bosco, P. Calvini, G. Gemme, M. Esposito, and C. Olivieri et al. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease Neuroimage 58 2011 469 480
78. Y. Li, Y. Wang, G. Wu, F. Shi, L. Zhou, W. Lin, and D. Shen Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features Neurobiol Aging 33 427 2012 e15 30
79. O. Querbes, F. Aubry, J. Pariente, J.A. Lotterie, J.F. Demonet, and V. Duret et al. Early diagnosis of Alzheimer's disease using cortical thickness: Impact of cognitive reserve Brain 132 2009 2036 2047
80. C.Y. Wee, P.T. Yap, and D. Shen Prediction of Alzheimer's disease and mild cognitive impairment using cortical morphological patterns Hum Brain Mapp 34 2013 3411 3425
81. S.F. Eskildsen, P. Coupe, D. Garcia-Lorenzo, V. Fonov, J.C. Pruessner, and D.L. Collins Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning Neuroimage 65 2013 511 521
82. E. Westman, J.S. Muehlboeck, and A. Simmons Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion Neuroimage 62 2012 229 238
83. X. Yang, M.Z. Tan, and A. Qiu CSF and brain structural imaging markers of the Alzheimer's pathological cascade PLoS One 7 2012 e47406
84. K.B. Walhovd, A.M. Fjell, J. Brewer, L.K. McEvoy, C. Fennema-Notestine, and D.J. Hagler Jr et al. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease AJNR Am J Neuroradiol 31 2010 347 354
85. D. Zhang, and D. Shen Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease Neuroimage 59 2012 895 907
86. B. Schmand, P. Eikelenboom, and W.A. van Gool Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment J Alzheimer Dis 29 2012 641 648
87. A.L. Gross, J.J. Manly, J. Pa, J.K. Johnson, L.Q. Park, and M.B. Mitchell et al. Cortical signatures of cognition and their relationship to Alzheimer's disease Brain Imaging Behav 6 2012 584 598
88. D.P. Devanand, X. Liu, P.J. Brown, E.D. Huey, Y. Stern, and G.H. Pelton A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease Int J Alzheimer Dis 2012 2012 483469
89. C. Hinrichs, V. Singh, G. Xu, and S.C. Johnson Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population Neuroimage 55 2011 574 589
90. D. Heister, J.B. Brewer, S. Magda, K. Blennow, and L.K. McEvoy Predicting MCI outcome with clinically available MRI and CSF biomarkers Neurology 77 2011 1619 1628
91. B. Zhou, E. Nakatani, S. Teramukai, Y. Nagai, and M. Fukushima Risk classification in mild cognitive impairment patients for developing Alzheimer's disease J Alzheimer Dis 30 2012 367 375
92. Y. Cui, B. Liu, S. Luo, X. Zhen, M. Fan, and T. Liu et al. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors PLoS One 6 2011 e21896
93. J. Ye, M. Farnum, E. Yang, R. Verbeeck, V. Lobanov, and N. Raghavan et al. Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data BMC Neurol 12 2012 46
94. J.J. Gomar, M.T. Bobes-Bascaran, C. Conejero-Goldberg, P. Davies, and T.E. Goldberg Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative Arch Gen Psychiatry 68 2011 961 969
95. J. Mattila, J. Koikkalainen, A. Virkki, A. Simonsen, M. van Gils, and G. Waldemar et al. A disease state fingerprint for evaluation of Alzheimer's disease J Alzheimer Dis 27 2011 163 176
96. J.L. Shaffer, J.R. Petrella, F.C. Sheldon, K.R. Choudhury, V.D. Calhoun, and R.E. Coleman et al. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers Radiology 266 2013 583 591
97. K. Chen, N. Ayutyanont, J.B. Langbaum, A.S. Fleisher, C. Reschke, and W. Lee et al. Characterizing Alzheimer's disease using a hypometabolic convergence index Neuroimage 56 2011 52 60
98. S.M. Landau, D. Harvey, C.M. Madison, E.M. Reiman, N.L. Foster, and P.S. Aisen et al. Comparing predictors of conversion and decline in mild cognitive impairment Neurology 75 2010 230 238
99. D. Zhang, and D. Shen Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers PLoS One 7 2012 e33182
100. C.R. Jack Jr, F. Barkhof, M.A. Bernstein, M. Cantillon, P.E. Cole, and C. Decarli et al. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease Alzheimer Dement 7 2011 474 485 e474